Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients?

Isabel ConceiçãoIsabel de CastroAndrés DiazIsabel de Castro

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2022)

QST, in particular CDT, HP 5 and HP 0.5 modalities, seems a good tool to identify subclinical neuropathy in ATTRv amyloidosis carriers, with CDT showing a higher sensitivity to detect and early neuropathic involvement.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
multiple myeloma
peritoneal dialysis
high resolution